{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:47Z","timestamp":1787003627121,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","award":["12S006"],"award-info":[{"award-number":["12S006"]}],"id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hemorphins, short bioactive peptides produced by enzymatic cleavage of \u03b2-hemoglobin, exhibit antihypertensive properties by inhibiting angiotensin-1 converting enzyme (ACE1). ACE1 is a key player in the renin\u2013angiotensin system (RAS) and regulates blood pressure. ACE1 and its homolog, ACE2, which exhibit opposing activities in the RAS, share considerable similarity in their catalytic domains. The primary objective of this study was to identify and contrast the molecular mechanisms underlying the interaction of hemorphins of camels and that of other mammals with the two ACE homologs. In silico docking and molecular dynamics simulations were performed for ACE1 and ACE2, along with in vitro confirmatory assays for ACE1. The C-domain of ACE1, primarily involved in regulating blood pressure, was used along with the N-terminal peptidase domain of ACE2. The findings revealed conserved hemorphin interactions with equivalent regions of the two ACE homologs and differential residue-level interactions reflecting the substrate preferences of ACE1 and ACE2 considering their opposing functions. Therefore, conserved residue-level associations and implications of poorly conserved regions between the two ACE receptors may potentially guide the discovery of selective domain-specific inhibitors. The findings of this study can provide a basis for the treatment of related disorders in the future.<\/jats:p>","DOI":"10.1038\/s41598-023-30771-0","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T10:03:22Z","timestamp":1678097002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Interaction of hemorphins with ACE homologs"],"prefix":"10.1038","volume":"13","author":[{"given":"Amie","family":"Jobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Antony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhib","family":"Altabbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusra","family":"Al Dhaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"30771_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1399-3011.1992.tb00277.x","volume":"39","author":"J Erchegyi","year":"1992","unstructured":"Erchegyi, J., Kastin, A. J., Zadina, J. E. & Qiu, X.-D. Isolation of a heptapeptide Val-Val-Tyr-Pro-Trp-Thr-Gln (valorphin) with some opiate activity. Int. J. Pept. Protein Res. 39, 477\u2013484 (1992).","journal-title":"Int. J. Pept. Protein Res."},{"key":"30771_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/0006-291X(92)90699-L","volume":"184","author":"E-L Gl\u00e4msta","year":"1992","unstructured":"Gl\u00e4msta, E.-L., Meyerson, B., Silberring, J., Terenius, L. & Nyberg, F. Isolation of a hemoglobin-derived opioid peptide from cerebrospinal fluid of patients with cerebrovascular bleedings. Biochem. Biophys. Res. Commun. 184, 1060\u20131066 (1992).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"30771_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1006\/bbrc.1994.1943","volume":"202","author":"AA Karelin","year":"1994","unstructured":"Karelin, A. A., Philippova, M. M., Karelina, E. V. & Ivanov, V. T. Isolation of endogenous hemorphin-related hemoglobin fragments from bovine brain. Biochem. Biophys. Res. Commun. 202, 410\u2013415 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"30771_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1006\/bbrc.1993.1880","volume":"194","author":"K Nishimura","year":"1993","unstructured":"Nishimura, K. & Hazato, T. Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. Biochem. Biophys. Res. Commun. 194, 713\u2013719 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"30771_CR5","doi-asserted-by":"publisher","first-page":"14214","DOI":"10.1038\/s41598-020-71188-3","volume":"10","author":"A Ali","year":"2020","unstructured":"Ali, A. & Vijayan, R. Dynamics of the ACE2\u2013SARS-CoV-2\/SARS-CoV spike protein interface reveal unique mechanisms. Sci. Rep. 10, 14214 (2020).","journal-title":"Sci. Rep."},{"key":"30771_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/biom10030486","volume":"10","author":"A Ali","year":"2020","unstructured":"Ali, A. et al. Camel hemorphins exhibit a more potent angiotensin-I converting enzyme inhibitory activity than other mammalian hemorphins: An in silico and in vitro study. Biomolecules 10, 486 (2020).","journal-title":"Biomolecules"},{"key":"30771_CR7","doi-asserted-by":"publisher","first-page":"E1092","DOI":"10.1152\/ajpendo.00440.2007","volume":"293","author":"MG Wallis","year":"2007","unstructured":"Wallis, M. G., Lankford, M. F. & Keller, S. R. Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. Am. J. Physiol.-Endocrinol. Metab. 293, E1092\u2013E1102 (2007).","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"30771_CR8","doi-asserted-by":"publisher","first-page":"e61390","DOI":"10.7554\/eLife.61390","volume":"9","author":"N Zamorano Cuervo","year":"2020","unstructured":"Zamorano Cuervo, N. & Grandvaux, N. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife 9, e61390 (2020).","journal-title":"Elife"},{"key":"30771_CR9","doi-asserted-by":"publisher","unstructured":"Turner, A. J. ACE2 cell biology, regulation, and physiological functions. In The Protective Arm of the Renin Angiotensin System (RAS) 185\u2013189 (Elsevier, 2015) https:\/\/doi.org\/10.1016\/B978-0-12-801364-9.00025-0.","DOI":"10.1016\/B978-0-12-801364-9.00025-0"},{"key":"30771_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/eurheartj\/ehi043","volume":"26","author":"LS Zisman","year":"2005","unstructured":"Zisman, L. S. ACE and ACE2: A tale of two enzymes. Eur. Heart J. 26, 322\u2013324 (2005).","journal-title":"Eur. Heart J."},{"key":"30771_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/ph14030225","volume":"14","author":"MA Ayoub","year":"2021","unstructured":"Ayoub, M. A. & Vijayan, R. Hemorphins targeting G protein-coupled receptors. Pharmaceuticals 14, 225 (2021).","journal-title":"Pharmaceuticals"},{"key":"30771_CR12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3389\/fphar.2019.01258","volume":"10","author":"A Ali","year":"2019","unstructured":"Ali, A. et al. Positive modulation of angiotensin II type 1 receptor-mediated signaling by LVV\u2013hemorphin-7. Front. Pharmacol. 10, 1258 (2019).","journal-title":"Front. Pharmacol."},{"key":"30771_CR13","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3389\/fphar.2018.01579","volume":"9","author":"F-F Ma","year":"2019","unstructured":"Ma, F.-F. et al. Three novel ACE inhibitory peptides isolated from ginkgo biloba seeds: Purification, inhibitory kinetic and mechanism. Front. Pharmacol. 9, 1579 (2019).","journal-title":"Front. Pharmacol."},{"key":"30771_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1042\/BJ20102123","volume":"436","author":"M Akif","year":"2011","unstructured":"Akif, M. et al. Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide. Biochem. J. 436, 53\u201359 (2011).","journal-title":"Biochem. J."},{"key":"30771_CR15","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1042\/CS20200899","volume":"134","author":"L Lubbe","year":"2020","unstructured":"Lubbe, L., Cozier, G. E., Oosthuizen, D., Acharya, K. R. & Sturrock, E. D. ACE2 and ACE: Structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV. Clin. Sci. 134, 2851\u20132871 (2020).","journal-title":"Clin. Sci."},{"key":"30771_CR16","unstructured":"Schr\u00f6dinger Release 2022-1: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2021. Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY, 2021. (2021)."},{"key":"30771_CR17","doi-asserted-by":"publisher","first-page":"17132","DOI":"10.1074\/jbc.M006723200","volume":"276","author":"H Zhang","year":"2001","unstructured":"Zhang, H. et al. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J. Biol. Chem. 276, 17132\u201317139 (2001).","journal-title":"J. Biol. Chem."},{"key":"30771_CR18","doi-asserted-by":"publisher","first-page":"14747","DOI":"10.1038\/s41598-019-50619-w","volume":"9","author":"A Ali","year":"2019","unstructured":"Ali, A., Baby, B., Soman, S. S. & Vijayan, R. Molecular insights into the interaction of hemorphin and its targets. Sci. Rep. 9, 14747 (2019).","journal-title":"Sci. Rep."},{"key":"30771_CR19","doi-asserted-by":"publisher","first-page":"17996","DOI":"10.1074\/jbc.M311191200","volume":"279","author":"P Towler","year":"2004","unstructured":"Towler, P. et al. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 279, 17996\u201318007 (2004).","journal-title":"J. Biol. Chem."},{"key":"30771_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1590\/S1984-82502012000400019","volume":"48","author":"MPC Silvestre","year":"2012","unstructured":"Silvestre, M. P. C. et al. Analysis of whey protein hydrolysates: Peptide profile and ACE inhibitory activity. Braz. J. Pharm. Sci. 48, 747\u2013757 (2012).","journal-title":"Braz. J. Pharm. Sci."},{"key":"30771_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/1541-4337.12051","volume":"13","author":"A Iwaniak","year":"2014","unstructured":"Iwaniak, A., Minkiewicz, P. & Darewicz, M. Food-originating ACE inhibitors, including antihypertensive peptides, as preventive food components in blood pressure reduction: Food peptides reducing blood pressure\u2026. Compr. Rev. Food Sci. Food Saf. 13, 114\u2013134 (2014).","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"30771_CR22","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S0196-9781(02)00083-9","volume":"23","author":"I Fruitier-Arnaudin","year":"2002","unstructured":"Fruitier-Arnaudin, I., Cohen, M., Bordenave, S., Sannier, F. & Piot, J.-M. Comparative effects of angiotensin IV and two hemorphins on angiotensin-converting enzyme activity. Peptides 23, 1465\u20131470 (2002).","journal-title":"Peptides"},{"key":"30771_CR23","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.3390\/md12073917","volume":"12","author":"R Liu","year":"2014","unstructured":"Liu, R. et al. Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (nano-LC-ESI-MS) and molecular docking. Mar. Drugs 12, 3917\u20133928 (2014).","journal-title":"Mar. Drugs"},{"key":"30771_CR24","first-page":"2107","volume":"53","author":"M Kohmura","year":"1989","unstructured":"Kohmura, M. et al. Inhibition of angiotensin-converting enzyme by synthetic peptides of human \u03b2-casein. Agric. Biol. Chem. 53, 2107\u20132114 (1989).","journal-title":"Agric. Biol. Chem."},{"key":"30771_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12010-016-2198-1","volume":"181","author":"A Moayedi","year":"2017","unstructured":"Moayedi, A. et al. ACE-inhibitory and antioxidant activities of peptide fragments obtained from tomato processing by-products fermented using bacillus subtilis: Effect of amino acid composition and peptides molecular mass distribution. Appl. Biochem. Biotechnol. 181, 48\u201364 (2017).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"30771_CR26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/s41598-020-58138-9","volume":"10","author":"P Kesari","year":"2020","unstructured":"Kesari, P. et al. Structural characterization and in-silico analysis of Momordica charantia 7S globulin for stability and ACE inhibition. Sci. Rep. 10, 1160 (2020).","journal-title":"Sci. Rep."},{"key":"30771_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/md15020029","volume":"15","author":"L Sun","year":"2017","unstructured":"Sun, L. et al. Separation and characterization of angiotensin I converting enzyme (ACE) inhibitory peptides from Saurida elongata proteins hydrolysate by IMAC-Ni2+. Mar. Drugs 15, 29 (2017).","journal-title":"Mar. Drugs"},{"key":"30771_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1006\/bbrc.1994.2447","volume":"204","author":"QY Zhao","year":"1994","unstructured":"Zhao, Q. Y., Sannier, F., Garreau, I., Guillochon, D. & Piot, J. M. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate. Biochem. Biophys. Res. Commun. 204, 216\u2013223 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"30771_CR29","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1111\/j.1742-4658.2005.04756.x","volume":"272","author":"JL Guy","year":"2005","unstructured":"Guy, J. L., Jackson, R. M., Jensen, H. A., Hooper, N. M. & Turner, A. J. Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J. 272, 3512\u20133520 (2005).","journal-title":"FEBS J."},{"key":"30771_CR30","doi-asserted-by":"publisher","first-page":"11852","DOI":"10.1021\/ja0277226","volume":"124","author":"NA Dales","year":"2002","unstructured":"Dales, N. A. et al. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc. 124, 11852\u201311853 (2002).","journal-title":"J. Am. Chem. Soc."},{"key":"30771_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nature01370","volume":"421","author":"R Natesh","year":"2003","unstructured":"Natesh, R., Schwager, S. L. U., Sturrock, E. D. & Acharya, K. R. Crystal structure of the human angiotensin-converting enzyme\u2013lisinopril complex. Nature 421, 551\u2013554 (2003).","journal-title":"Nature"},{"key":"30771_CR32","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jmb.2006.01.048","volume":"357","author":"HR Corradi","year":"2006","unstructured":"Corradi, H. R., Schwager, S. L. U., Nchinda, A. T., Sturrock, E. D. & Acharya, K. R. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. J. Mol. Biol. 357, 964\u2013974 (2006).","journal-title":"J. Mol. Biol."},{"key":"30771_CR33","doi-asserted-by":"publisher","first-page":"12654","DOI":"10.1021\/bi061146z","volume":"45","author":"JM Watermeyer","year":"2006","unstructured":"Watermeyer, J. M. et al. Structure of testis ACE glycosylation mutants and evidence for conserved domain movement. Biochemistry 45, 12654\u201312663 (2006).","journal-title":"Biochemistry"},{"key":"30771_CR34","unstructured":"Schr\u00f6dinger Release 2022-1: Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2021. (2021)."},{"key":"30771_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221\u2013234 (2013).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"30771_CR36","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739\u20131749 (2004).","journal-title":"J. Med. Chem."},{"key":"30771_CR37","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes. J. Med. Chem. 49, 6177\u20136196 (2006).","journal-title":"J. Med. Chem."},{"key":"30771_CR38","unstructured":"Schr\u00f6dinger Release 2022-1: Maestro, Schr\u00f6dinger, LLC, New York, NY, 2021. (2021)."},{"key":"30771_CR39","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li, J. et al. The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins 79, 2794\u20132812 (2011).","journal-title":"Proteins"},{"key":"30771_CR40","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark, P. & Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J. Phys. Chem. A 105, 9954\u20139960 (2001).","journal-title":"J. Phys. Chem. A"},{"key":"30771_CR41","doi-asserted-by":"publisher","unstructured":"Zhang, J., Hou, Y., Wang, Y., Wang, C. & Zhang, X. The LBFGS Quasi-Newtonian method for molecular modeling prion AGAAAAGA amyloid fibrils https:\/\/doi.org\/10.48550\/ARXIV.1206.1755 (2012).","DOI":"10.48550\/ARXIV.1206.1755"},{"key":"30771_CR42","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1063\/1.463940","volume":"97","author":"GJ Martyna","year":"1992","unstructured":"Martyna, G. J., Klein, M. & Tuckerman, M. Nos\u00e9-Hoover chains: The canonical ensemble via continuous dynamics: The Journal of Chemical Physics: Vol 97, No 4. J. Chem. Phys. 97, 2635\u20132643 (1992).","journal-title":"J. Chem. Phys."},{"key":"30771_CR43","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna, G. J., Tobias, D. J. & Klein, M. L. Constant pressure molecular dynamics algorithms. J. Chem. Phys. 101, 4177\u20134189 (1994).","journal-title":"J. Chem. Phys."},{"key":"30771_CR44","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577\u20138593 (1995).","journal-title":"J. Chem. Phys."},{"key":"30771_CR45","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1021\/j100078a035","volume":"98","author":"DD Humphreys","year":"1994","unstructured":"Humphreys, D. D., Friesner, R. A. & Berne, B. J. A multiple-time-step molecular dynamics algorithm for macromolecules. J. Phys. Chem. 98, 6885\u20136892 (1994).","journal-title":"J. Phys. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30771-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30771-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30771-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T10:18:43Z","timestamp":1678097923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30771-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["30771"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-30771-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.V. is an editorial board member of Scientific Reports. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3743"}}